Synthace - About the company
Synthace is a series C company based in London (United Kingdom), founded in 2011 by Markus Christian Gershater. It operates as a Developer of software for automating biological experiments and data analysis. Synthace has raised $80.3M in funding from investors like Horizons Ventures, Sofinnova Partners and Amadeus Capital, with a current valuation of $*****. The company has 403 active competitors, including 42 funded and 52 that have exited. Its top competitors include companies like Cirdan Imaging, Ovation and Quartzy.
Company Details
Developer of software for automating biological experiments and data analysis. This platform enables the design and execution of multivariate experiments to generate structured datasets. It integrates with laboratory hardware to manage experimental workflows and standardize data collection. The software assists in assay development, media optimization, and purification processes by facilitating the management of experimental variables.
- Website
- www.synthace.com/
- Email ID
- *****@synthace.com
- Phone Number
- +44 **********
- Registered Address
- WEST WORKS,195 WOOD LANE,LONDON,ENGLAND,W12 7FQ
Key Metrics
Founded Year
2011
Location
London, United Kingdom
Stage
Series C
Total Funding
$80.3M in 8 rounds
Latest Funding Round
Post Money Valuation
$***** as on Dec 04, 2018
Investors
Ranked
9th among 403 active competitors
Annual Revenue
£1M - £10M as on May 31, 2025
Employee Count
32 as on Sep 30, 2026
Legal entities associated with Synthace
Synthace is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Synthace Limited CIN: 7652459 , United Kingdom, Active | May 30, 2011 | £1M - £10M (As on May 31, 2025) | 61 (As on Jan 31, 2024) | |
Synthace Ltd CIN: 7652459 , Germany, Active | May 30, 2011 | £1M - £10M (As on Jan 31, 2023) | 71 (As on Jan 31, 2021) |
Sign up to download Synthace's company profile
Synthace's funding and investors
Synthace has raised a total funding of $80.3M over 8 rounds. Its first funding round was on Apr 12, 2012. Its latest funding round was a Series C round on Nov 16, 2021 for $*****. 2 investors participated in its latest round. Synthace has 22 institutional investors and 36 angel investors.
Here is the list of recent funding rounds of Synthace:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 16, 2021 | 8346714 | Series C | 5664645 | 8950878 | 1699557 | 7387289 |
Dec 12, 2018 | 3727453 | Series B | 5756363 | 1550858 | 5141008 | |
May 23, 2018 | 7349887 | Series A | 1845192 | 2607643 | 5418908 | 4406730 |
View details of Synthace's funding rounds and investors
Synthace's founders and board of directors
Founder? Claim ProfileThe founders of Synthace is Markus Christian Gershater. Markus Christian Gershater is the CEO of Synthace.
Here are the details of Synthace's key team members:
- Markus Christian Gershater: Co-Founder & CEO of Synthace. They serve on the board of 1 company.Contact Info: 1 email address
Synthace's Board of Directors
Synthace's board has 3 active members. Markus Christian Gershater and Willem George Baralt are part of team and Jacques Theurillat is independent board member.Here is the list of Synthace's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 7y 6m | |
aasjnoq | Team | - | Current | 4y 3m |
Independent board member | - | Current | 1y 2m |
View details of Synthace's Founder profiles and Board Members
Synthace's employee count trend
Synthace has 32 employees as of Sep 26. Here is Synthace's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Synthace's Competitors and alternates
Top competitors of Synthace include Cirdan Imaging, Ovation and Quartzy. Here is the list of Top 10 competitors of Synthace, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cirdan Imaging 2010, Lisburn (United Kingdom), Series B | Laboratory Information System for clinical laboratories | $27.6M | 65/100 | |
2nd | Ovation 2009, Cambridge (United States), Series B | Provider of a cloud-based laboratory information and data management platform for researchers and clinicians | $33.3M | 65/100 | |
3rd | Quartzy 2009, Hayward (United States), Series C | Provider of web-based platform for labs management | $56.9M | 65/100 | |
4th | Automata 2015, London (United Kingdom), Series C | Developer of modular lab automation platforms for biological research workflows | $177M | 63/100 | |
5th | Uncountable Data 2016, San Francisco (United States), Series A | Developer of a unified platform for research and development data management | $27M | 63/100 | |
6th | Developer of no-code informatics platforms for life science research laboratories | $8.12M | 60/100 | ||
7th | Elemental Machines 2015, Cambridge (United States), Series B | Provider of data driven drug discovery and development platform for various industries | $52.3M | 57/100 | |
8th | Network of pathologists providing digital diagnostic services for medical testing | $56.6M | 57/100 | ||
9th | Synthace 2011, London (United Kingdom), Series C | Developer of software for automating biological experiments and data analysis | $80.3M | 56/100 | |
10th | Labvantage 1989, Somerset (United States), Funding Raised | Laboratory informatics platform streamlining lab data for informed business decisions | - | 55/100 |
Looking for more details on Synthace's competitors? Click here to see the top ones
Synthace's Investments and acquisitions
Synthace has made no investments or acquisitions yet.
Reports related to Synthace
Here is the latest report on Synthace's sector:
News related to Synthace
Media has covered Synthace for 1 event in last 1 year, It was about partnerships.
•
Synthace Collaborates with Charles River on Assay DevelopmentEuropean Pharmaceutical Manufacturer•Feb 09, 2026•Synthace, Charles River Laboratories
•
•
Synthace combines ChatGPT and digital experiments in first step toward a true AI scientistBusiness Wire•May 24, 2023•Synthace, OpenAI
•
Synthace, a Digital Experiment Platform for Life Science R&D, Records Strongest Year YetBusiness Wire•Apr 05, 2023•Synthace
•
•
UCL Selects Synthace to Help Make Digital, Cloud-Based Lab Work a RealityBusiness Wire•Apr 05, 2022•UCL, Synthace
•
Synthace Raises $35M in Series C FundingFinSMEs•Nov 16, 2021•Synthace, Horizons Ventures, Sofinnova Partners
•
Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for ScientistsFinancial Buzz•Aug 02, 2021•Synthace
•
Synthace More Than Doubles Its Annual Recurring Revenue; Expands Customer Footprint With the Top Pharma Companies In 2020Business Wire•Mar 25, 2021•Synthace
•
Synthace Appoints Dr. Nick Jurascheck as VP of EngineeringBusiness Wire•Mar 09, 2021•Synthace, McLaren
Are you a Founder ?
FAQs about Synthace
Explore our recently published companies
- Study Bridge Overseas - Unfunded company
- HDD Stock Room - 2018 founded, Unfunded company
- Spairts - Unfunded company
- Specs - Malpas based, Unfunded company
- Wolf-Tabakwaren - Germany based, Unfunded company
- Vidocq AI - San Francisco based, Unfunded company
